InChIKey	BPZSYCZIITTYBL-UHFFFAOYSA-N
Compound Name	Formoterol
Canonical SMILES	COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	7.54
Source	ChEMBL;BindingDB

DrugBank ID	DB00983
Drug Name	Formoterol
CAS Number	73573-87-2
Groups	approved investigational
ATC Codes	R03AL09 R03AL05 R03AK09 R03AL10 R03CC15 R03AL11 R03AL07 R03AK08 R03AC13 R03AK07 R03AK11
Description	Formoterol is an inhaled beta<sub>2</sub>-agonist used in the management of COPD and asthma that was first approved for use in the United States in 2001.[L10986] It acts on bronchial smooth muscle to dilate and relax airways, and is administered as a racemic mixture of its active (R;R)- and inactive...

---

Categories: Adrenergic Agents Adrenergic Agonists Adrenergic beta-2 Receptor Agonists Adrenergic beta-Agonists Adrenergics for Systemic Use Adrenergics, Inhalants Agents producing tachycardia Agents that produce hypertension Agents to Treat Airway Disease Alcohols Amines Amino Alcohols Anti-Asthmatic Agents Autonomic Agents Bronchodilator Agents Cytochrome P-450 CYP2A6 Substrates Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 Substrates Drugs for Obstructive Airway Diseases Ethanolamines Long-acting beta-adrenoceptor agonists OCT1 inhibitors OCT1 substrates Potential QTc-Prolonging Agents QTc Prolonging Agents Respiratory System Agents Selective Beta 2-adrenergic Agonists UGT1A1 Substrates UGT1A9 Substrates UGT2B7 substrates

---

Cross-references: BindingDB: 86453 ChEBI: 63082 CHEMBL1256786 ChemSpider: 3292 Drugs Product Database (DPD): 11381 Guide to Pharmacology: 3465 IUPHAR: 3465 C07805 D07990 PharmGKB: PA134687907 PubChem:3410 PubChem:46507099 RxCUI: 25255 Therapeutic Targets Database: DAP000247 Wikipedia: Formoterol